Cundy; Kenneth C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cundy; Kenneth C..The latest application filed is for "therapeutic peptides".

Company Profile

5.52.71

Cundy; Kenneth C. - Atherton CA
Cundy; Kenneth C. - Redwood City CA
Cundy; Kenneth C. - Belmont CA
Cundy, Kenneth C - Redqood City CA
Cundy; Kenneth C. - Pottstown PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutic peptides Grant 11,332,497 - Cundy , et al. May 17, 2	2022-05-17
Therapeutic Peptides App 20210363187 - Cundy; Kenneth C. ; et al.	2021-11-25
Therapeutic peptides Grant 11,111,271 - Cundy , et al. September 7, 2	2021-09-07
Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects Grant 10,945,984 - Cundy , et al. March 16, 2	2021-03-16
Gaba Analog Prodrug Sustained Release Oral Dosage Forms App 20200323804 - Cundy; Kenneth C. ; et al.	2020-10-15
Therapeutic Peptides App 20200181197 - Cundy; Kenneth C. ; et al.	2020-06-11
Gaba Analog Prodrug Sustained Release Oral Dosage Forms App 20200147019 - Cundy; Kenneth C. ; et al.	2020-05-14
Gaba Analog Prodrug Sustained Release Oral Dosage Forms App 20190247345 - Cundy; Kenneth C. ; et al.	2019-08-15
Gaba Analog Prodrug Sustained Release Oral Dosage Forms App 20180207117 - Cundy; Kenneth C. ; et al.	2018-07-26
GABA analog prodrug sustained release oral dosage forms Grant 9,949,941 - Cundy , et al. April 24, 2	2018-04-24
Gaba Analog Prodrug Sustained Release Oral Dosage Forms App 20170071888 - Cundy; Kenneth C. ; et al.	2017-03-16
Methods Of Administering Monomethyl Fumarate App 20150190360 - Cundy; Kenneth C.	2015-07-09
Gaba Analog Prodrug Sustained Release Oral Dosage Forms App 20150072004 - Cundy; Kenneth C. ; et al.	2015-03-12
Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of use Grant 8,952,006 - Cundy , et al. February 10, 2	2015-02-10
GABA analog prodrug sustained release oral dosage forms Grant 8,906,412 - Cundy , et al. December 9, 2	2014-12-09
Methods of Administering Monomethyl Fumarate and Prodrugs Thereof Having Reduced Side Effects App 20140350018 - Cundy; Kenneth C. ; et al.	2014-11-27
Gaba Analog Prodrug Sustained Release Oral Dosage Forms App 20140302140 - Cundy; Kenneth C. ; et al.	2014-10-09
Methods of Administering Monomethyl Fumarate App 20140275250 - Cundy; Kenneth C.	2014-09-18
GABA analog prodrug sustained release oral dosage forms Grant 8,795,725 - Cundy , et al. August 5, 2	2014-08-05
Methods of Use for Monomethyl Fumarate and Prodrugs Thereof App 20140057918 - Wustrow; David J. ; et al.	2014-02-27
Methods of Administering Monomethyl Fumarate and Prodrugs Thereof Having Reduced Side Effects App 20140057917 - Cundy; Kenneth C. ; et al.	2014-02-27
Morpholinoalkyl Fumarate Compounds, Pharmaceutical Compositions, and Methods of Use App 20140051705 - Cundy; Kenneth C. ; et al.	2014-02-20
Morpholinoalkyl Fumarate Compounds, Pharmaceutical Compositions, And Methods Of Use App 20130203753 - Cundy; Kenneth C. ; et al.	2013-08-08
Prodrugs Of Gaba Analogs, Compositions And Uses Thereof App 20130102641 - Gallop; Mark A. ; et al.	2013-04-25
Methods of using prodrugs of pregabalin Grant 8,367,722 - Gallop , et al. February 5, 2	2013-02-05
Levodopa Prodrugs, and Compositions and Uses Thereof App 20120190861 - Xiang; Jia-Ning ; et al.	2012-07-26
Prodrugs of GABA analogs, compositions and uses thereof Grant 8,168,623 - Gallop , et al. May 1, 2	2012-05-01
Levodopa prodrugs, and compositions and uses thereof Grant 8,163,958 - Xiang , et al. April 24, 2	2012-04-24
Use Of Prodrugs Of Gaba Analogs For Treating Diseases App 20120041061 - Barrett; Ronald W. ; et al.	2012-02-16
Methods Of Using Prodrugs Of Pregabalin App 20120035258 - Gallop; Mark A. ; et al.	2012-02-09
Prodrugs of GABA analogs, compositions and uses thereof Grant 8,048,917 - Gallop , et al. November 1, 2	2011-11-01
Levodopa Prodrugs, And Compositions And Uses Thereof App 20110201817 - XIANG; Jia-Ning ; et al.	2011-08-18
Levodopa prodrugs, and compositions and uses thereof Grant 7,956,212 - Xiang , et al. June 7, 2	2011-06-07
Prodrugs Of Gaba Analogs, Compositions And Uses Thereof App 20100267946 - Gallop; Mark A. ; et al.	2010-10-21
Gemcitabine prodrugs, pharmaceutical compositions and uses thereof Grant 7,803,785 - Gallop , et al. September 28, 2	2010-09-28
Prodrugs of GABA analogs, compositions and uses thereof Grant 7,790,708 - Gallop , et al. September 7, 2	2010-09-07
Levodopa Prodrugs, And Compositions And Uses Thereof App 20100197953 - Xiang; Jia-Ning ; et al.	2010-08-05
Amino acid conjugates providing for sustained systemic concentrations of GABA analogues Grant 7,767,649 - Scheuerman , et al. August 3, 2	2010-08-03
Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs Grant 7,678,782 - Gallop , et al. March 16, 2	2010-03-16
Levodopa prodrugs, and compositions and uses thereof Grant 7,671,089 - Xiang , et al. March 2, 2	2010-03-02
Gemcitabine Prodrugs, Pharmaceutical Compositions And Uses Thereof App 20100016254 - Gallop; Mark A. ; et al.	2010-01-21
Amino acid conjugates providing for sustained systemic concentrations of GABA analogues Grant 7,645,797 - Gallop , et al. January 12, 2	2010-01-12
Levodopa Prodrugs, and Compositions and Uses Thereof App 20100004332 - Xiang; Jia-Ning ; et al.	2010-01-07
Gemcitabine prodrugs, pharmaceutical compositions and uses thereof Grant 7,608,602 - Gallop , et al. October 27, 2	2009-10-27
Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration Grant 7,601,708 - Cundy , et al. October 13, 2	2009-10-13
Bile-acid conjugates providing for sustained systemic concentration of drugs Grant 7,601,706 - Cundy , et al. October 13, 2	2009-10-13
Bile-acid conjugates for providing sustained systemic concentrations of drugs Grant 7,598,235 - Cundy , et al. October 6, 2	2009-10-06
Substrates And Screening Methods For Transport Proteins App 20090221442 - Dower; William J. ; et al.	2009-09-03
Sustained Release Particulate Oral Dosage Forms of (R) Baclofen and Methods of Treatment App 20090197958 - SASTRY; Srikonsda ; et al.	2009-08-06
Nucleotide Analogs App 20090149648 - Bischofberger; Norbert W. ; et al.	2009-06-11
Levodopa Prodrugs, And Compositions And Uses Thereof App 20090137834 - Xiang; Jia-Ning ; et al.	2009-05-28
Levodopa prodrugs, and compositions and uses thereof Grant 7,534,813 - Xiang , et al. May 19, 2	2009-05-19
Use Of Prodrugs Of Gaba Analogs, Antispasticity Agents, And Prodrugs Of Gaba B Receptor Agonists For Treating Spasticity App 20090041806 - CUNDY; Kenneth C.	2009-02-12
Use Of Propofol Prodrugs For Treating Alcohol Withdrawal, Central Pain, Anxiety Or Pruritus App 20090005444 - Cundy; Kenneth C. ; et al.	2009-01-01
Nucleotide analogs Grant 7,439,350 - Bischofberger , et al. October 21, 2	2008-10-21
Compounds For Sustained Release Of Orally Delivered Drugs App 20080255073 - GALLOP; Mark A. ; et al.	2008-10-16
Amino Acid Conjugates Providing For Sustained Systemic Concentration Of Gaba Analogues App 20080226716 - Gallop; Mark ; et al.	2008-09-18
Amino acid conjugates providing for sustained systemic concentrations of GABA analogues Grant 7,420,002 - Gallop , et al. September 2, 2	2008-09-02
Sustained Release Oral Dosage Forms Of A Prodrug Of R-baclofen And Methods Of Treatment App 20080206332 - Kidney; David J. ; et al.	2008-08-28
Substrates and screening methods for transport proteins Grant 7,413,536 - Dower , et al. August 19, 2	2008-08-19
Use of prodrugs of GABA analogs for treating disease App 20080161393 - Barrett; Ronald W. ; et al.	2008-07-03
Levodopa prodrugs, and compositions and uses thereof App 20080103200 - Xiang; Jia-Ning ; et al.	2008-05-01
Levodopa prodrugs, and compositions and uses thereof Grant 7,342,131 - Xiang , et al. March 11, 2	2008-03-11
Levodopa prodrugs, and compositions and uses thereof Grant 7,323,585 - Xiang , et al. January 29, 2	2008-01-29
Gemcitabine Prodrugs, Pharmaceutical Compositions and Uses Thereof App 20080021208 - Gallop; Mark A. ; et al.	2008-01-24
Gemcitabine prodrugs, pharmaceutical compositions and uses thereof Grant 7,265,096 - Gallop , et al. September 4, 2	2007-09-04
Amino acid conjugates providing for sustained systemic concentrations of GABA analogues App 20070135356 - Scheuerman; Randall A. ; et al.	2007-06-14
Amino acid derived prodrugs of propofol, compositions and uses thereof Grant 7,220,875 - Gallop , et al. May 22, 2	2007-05-22
Prodrugs of GABA analogs, compositions and uses thereof Grant 7,186,855 - Gallop , et al. March 6, 2	2007-03-06
Amino acid conjugates providing for sustained systemic concentrations of GABA analogues Grant 7,183,259 - Scheuerman , et al. February 27, 2	2007-02-27
Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs App 20070015716 - Gallop; Mark A. ; et al.	2007-01-18
Prodrugs of GABA analogs, compositions and uses thereof App 20070010453 - Gallop; Mark A. ; et al.	2007-01-11
Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs Grant 7,144,877 - Gallop , et al. December 5, 2	2006-12-05
Prodrugs of GABA analogs, compositions and uses thereof App 20060229361 - Gallop; Mark A. ; et al.	2006-10-12
Carbidopa prodrugs and derivatives, and compositions and uses thereof Grant 7,101,912 - Xiang , et al. September 5, 2	2006-09-05
Bile-acid conjugates providing for sustained systemic concentration of drugs App 20060166858 - Cundy; Kenneth C. ; et al.	2006-07-27
GABA analog prodrug sustained release oral dosage forms App 20060141034 - Cundy; Kenneth C. ; et al.	2006-06-29
Bile-acid conjugates providing for sustained systemic concentration of drugs Grant 7,049,305 - Cundy , et al. May 23, 2	2006-05-23
Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration Grant 6,992,076 - Cundy , et al. January 31, 2	2006-01-31
Levodopa prodrugs, and compositions and uses thereof App 20060020028 - Xiang; Jia-Ning ; et al.	2006-01-26
Bile-acid conjugates for providing sustained systemic concentrations of drugs Grant 6,984,634 - Cundy , et al. January 10, 2	2006-01-10
Bile-acid conjugates for providing sustained systemic concentrations of drugs App 20050288228 - Cundy, Kenneth C. ; et al.	2005-12-29
Levodopa prodrugs, and compositions and uses thereof App 20050282891 - Xiang, Jia-Ning ; et al.	2005-12-22
Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration App 20050272710 - Cundy, Kenneth C. ; et al.	2005-12-08
Prodrugs of GABA analogs, compositions and uses thereof Grant 6,972,341 - Gallop , et al. December 6, 2	2005-12-06
Treatment of local pain App 20050209319 - Cundy, Kenneth C.	2005-09-22
Bile-acid conjugates providing for sustained systemic concentration of drugs App 20050148564 - Cundy, Kenneth C. ; et al.	2005-07-07
Bile-acid conjugates for providing sustained systemic concentrations of drugs Grant 6,900,192 - Cundy , et al. May 31, 2	2005-05-31
Compounds for sustained release of orally delivered drugs App 20050054559 - Gallop, Mark A. ; et al.	2005-03-10
Amino acid derived prodrugs of propofol, compositions and uses thereof App 20050004381 - Gallop, Mark A. ; et al.	2005-01-06
Orally administered dosage forms of GABA analog prodrugs having reduced toxicity Grant 6,833,140 - Cundy , et al. December 21, 2	2004-12-21
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues App 20040254344 - Gallop, Mark ; et al.	2004-12-16
Nucleotide analogs App 20040242465 - Bischofberger, Norbert W. ; et al.	2004-12-02
Prodrugs of GABA analogs, compositions and uses thereof Grant 6,818,787 - Gallop , et al. November 16, 2	2004-11-16
Orally administered dosage forms of gaba analog prodrugs having reduced toxicity App 20040198820 - Cundy, Kenneth C. ; et al.	2004-10-07
Carbidopa prodrugs and derivatives, and compositions and uses thereof App 20040167216 - Xiang, Jia-Ning ; et al.	2004-08-26
Gemcitabine prodrugs, pharmaceutical compositions and uses thereof App 20040142857 - Gallop, Mark A. ; et al.	2004-07-22
Prodrugs of GABA analogs, compositions and uses thereof App 20040077553 - Gallop, Mark A. ; et al.	2004-04-22
Prodrugs of gaba analogs, compositions and uses thereof App 20040006132 - Gallop, Mark A. ; et al.	2004-01-08
Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability Grant RE38,333 - Arimilli , et al. November 25, 2	2003-11-25
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues App 20030216466 - Scheuerman, Randall A. ; et al.	2003-11-20
Amino acid conjugates providing for sustained systemic concentrations of GABA analogues App 20030181390 - Gallop, Mark A. ; et al.	2003-09-25
Prodrugs of GABA analogs, compositions and uses thereof App 20030176398 - Gallop, Mark A. ; et al.	2003-09-18
Administrative agents via the SMVT transporter App 20030158089 - Gallop, Mark A. ; et al.	2003-08-21
Engineering absorption of therapeutic compounds via colonic transporters App 20030158254 - Zerangue, Noa ; et al.	2003-08-21
Orally administered dosage forms of GABA analog prodrugs having reduced toxicity App 20030083382 - Cundy, Kenneth C. ; et al.	2003-05-01
Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration App 20020151529 - Cundy, Kenneth C. ; et al.	2002-10-17
Bile-acid prodrugs of L-dopa and their use in the sustained treatment of parkinsonism App 20020151526 - Gallop, Mark A. ; et al.	2002-10-17
Bile-acid conjugates for providing sustained systemic concentrations of drugs App 20020142998 - Cundy, Kenneth C. ; et al.	2002-10-03
Bile-acid conjugates for providing sustained systemic concentrations of drugs App 20020111338 - Cundy, Kenneth C. ; et al.	2002-08-15
Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs App 20020099041 - Gallop, Mark A. ; et al.	2002-07-25
Compounds for sustained release of orally delivered drugs App 20020098999 - Gallop, Mark A. ; et al.	2002-07-25
Nucleotide analogs App 20010041794 - Bischofberger, Norbert W. ; et al.	2001-11-15
Nucleotide analogs Grant 6,225,460 - Bischofberger , et al. May 1, 2	2001-05-01
Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability Grant 6,069,249 - Arimilli , et al. May 30, 2	2000-05-30
Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability Grant 6,043,230 - Arimilli , et al. March 28, 2	2000-03-28
Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability Grant 5,977,089 - Arimilli , et al. November 2, 1	1999-11-02
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability Grant 5,922,695 - Arimilli , et al. July 13, 1	1999-07-13
Surface modified NSAID nanoparticles Grant 5,552,160 - Liversidge , et al. September 3, 1	1996-09-03
Method to reduce particle size growth during lyophilization Grant 5,302,401 - Liversidge , et al. April 12, 1	1994-04-12
Surface modified drug nanoparticles Grant 5,145,684 - Liversidge , et al. Sep	1992-09-08

Company Registrations

SEC

0001322959

Cundy Kenneth C

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.